Katherine Falloon

Jami Kinnucan, MD, is an inflammatory bowel disease (IBD) specialist who joined the Mayo Clinic Florida practice in January 2021 as an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology. She currently serves as the Clinical Practice Chair for the Division of Gastroenterology & Hepatology, Associate Chair for Digital Transformation and Practice Integration for the Department of Medicine and Medical Director for Plummer Chart Ambulatory Communication Solutions team. She is also the Director of the IBD Intestinal Ultrasound Program at Mayo Clinic Florida. She has been recognized as a fellow of the American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), and Crohn's and Colitis Foundation. She is a former member of the ACG Board of Governors for the state of Michigan and the ACG Women in Gastroenterology Committee. She is active in the Crohn’s and Colitis Foundation and previous Co-Chair for the Women in IBD Task Force and prior member of the Government and Industry Affairs Committee for the National Scientific Advisory Committee. Dr. Kinnucan is the co-founder of the Michigan GI Society in 2020 and, most recently, co-founded the Florida Women in GI (2022) and Gastro Digital Health (2024) She serves as Associate Editor for the Crohn’s and Colitis 360 Journal. She is actively involved with research looking at the impact of cannabis in IBD and received a 2024 Mayo Clinic STARDOM award to evaluate the use of virtual reality on the impact of pain in patients with abdominal pain and Crohn’s disease.

Professor Remo Panaccione is a Professor of Medicine and the Director of the Inflammatory Bowel Disease Unit at the University of Calgary, Canada. He serves as the Dean of MD Admissions and Director of the IBD Fellowship Program. He also holds the Crohn’s Colitis Canada Endowed Research Chair in Inflammatory Bowel Disease.

He is the 2020 Crohn's Colitis Canada Outstanding Physician of the Year and received the 2024 Crohn’s Colitis Canada Research Leadership Award for his contributions to the field. Since 2020 he has been a Clarivate Research Scholar for being cited in the top one percent of researchers in the world. He has co-authored over 500 manuscripts, 20 book chapters and 825 abstracts, including publications in journals such as the New England Journal of Medicine, The Lancet, JAMA, Nature, and Annals of Internal Medicine.

Prof. Panaccione’s main research interest is the design and implementation of clinical trials. He has been the principal investigator on several studies evaluating the efficacy and safety of new therapeutic agents in subjects with IBD.

Dr. Clarke is Professor and Chief of Gastroenterology and Hepatology, at The College of Medicine at Penn State Health Milton S. Hershey Medical Center. He is also the Graham Jeffries Endowed Professor of Medicine
Fellowships:
-Gastroenterology, Hepatology and Nutrition; University of Pittsburgh
-Research Fellowship; Michigan State University
Post Graduate:
-Medicine and Gastroenterology- Imperial College, Royal College of Physicians, London, UK

Additional Qualifications
-Certificate for Leadership Training for Physicians in Academic Medical Centers-
Harvard School of Public Health.
-Certificate of Completion, Penn State Leadership Academy

Clinical and Research Interests:
-Inflammatory Bowel Disease and Celiac Disease.
-Graduate Medical Education.

Katherine Falloon, MD, is a staff gastroenterologist at the Digestive Disease and Surgery Institute at the Cleveland Clinic and an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine. She is also the co-director of the intestinal ultrasound program at the Cleveland Clinic. Her clinical focus is in caring for patients in inflammatory bowel disease and her research interest is in extra-intestinal manifestations of inflammatory bowel disease. She is currently leading the Cohort for Healing Skin, Eye, and Extra-Intestinal Manifestations (CHASE-EIM), a multi-disciplinary research consortia related to extra-intestinal manifestations of inflammatory bowel disease. She has received funding from the Crohn's and Colitis Foundation, Pfizer, and the Digestive Disease and Surgery Institute's Chief Innovation and Research Award.

Jason Schairer is the Director of the Henry Ford IBD Center in Michigan. His interests include Interventional IBD with a focus on stricturotomy, addressing health care inequity, intimacy and sex in IBD, and improving medical education for providers of all levels. He received his medical degree from Wayne Statue University, and went on to complete a fellowship in gastroenterology at Providence Hospital in Michigan. He previously served as the Associate Program Director of the Henry Ford Gastroenterology and Hepatology fellowship, and continues to be involved in fellow education of IBD across the state of Michigan. He has been recognized for his teaching efforts, high quality care of IBD patients and contributions to patient education. He has presented at ESCCO, AIBD and DDW. He is Vice President of the Interventional IBD Special Interest Group of ASGE. He is President of the Oakland County Medical Society. He is also active on social media including Twitter and Youtube.

Jami Kinnucan, MD, is an inflammatory bowel disease (IBD) specialist who joined the Mayo Clinic Florida practice in January 2021 as an Associate Professor of Medicine in the Division of Gastroenterology and Hepatology. She currently serves as the Clinical Practice Chair for the Division of Gastroenterology & Hepatology, Associate Chair for Digital Transformation and Practice Integration for the Department of Medicine and Medical Director for Plummer Chart Ambulatory Communication Solutions team. She is also the Director of the IBD Intestinal Ultrasound Program at Mayo Clinic Florida. She has been recognized as a fellow of the American College of Gastroenterology (ACG), American Gastroenterological Association (AGA), and Crohn's and Colitis Foundation. She is a former member of the ACG Board of Governors for the state of Michigan and the ACG Women in Gastroenterology Committee. She is active in the Crohn’s and Colitis Foundation and previous Co-Chair for the Women in IBD Task Force and prior member of the Government and Industry Affairs Committee for the National Scientific Advisory Committee. Dr. Kinnucan is the co-founder of the Michigan GI Society in 2020 and, most recently, co-founded the Florida Women in GI (2022) and Gastro Digital Health (2024) She serves as Associate Editor for the Crohn’s and Colitis 360 Journal. She is actively involved with research looking at the impact of cannabis in IBD and received a 2024 Mayo Clinic STARDOM award to evaluate the use of virtual reality on the impact of pain in patients with abdominal pain and Crohn’s disease.

Professor Remo Panaccione is a Professor of Medicine and the Director of the Inflammatory Bowel Disease Unit at the University of Calgary, Canada. He serves as the Dean of MD Admissions and Director of the IBD Fellowship Program. He also holds the Crohn’s Colitis Canada Endowed Research Chair in Inflammatory Bowel Disease.

He is the 2020 Crohn's Colitis Canada Outstanding Physician of the Year and received the 2024 Crohn’s Colitis Canada Research Leadership Award for his contributions to the field. Since 2020 he has been a Clarivate Research Scholar for being cited in the top one percent of researchers in the world. He has co-authored over 500 manuscripts, 20 book chapters and 825 abstracts, including publications in journals such as the New England Journal of Medicine, The Lancet, JAMA, Nature, and Annals of Internal Medicine.

Prof. Panaccione’s main research interest is the design and implementation of clinical trials. He has been the principal investigator on several studies evaluating the efficacy and safety of new therapeutic agents in subjects with IBD.

Dr. Clarke is Professor and Chief of Gastroenterology and Hepatology, at The College of Medicine at Penn State Health Milton S. Hershey Medical Center. He is also the Graham Jeffries Endowed Professor of Medicine
Fellowships:
-Gastroenterology, Hepatology and Nutrition; University of Pittsburgh
-Research Fellowship; Michigan State University
Post Graduate:
-Medicine and Gastroenterology- Imperial College, Royal College of Physicians, London, UK

Additional Qualifications
-Certificate for Leadership Training for Physicians in Academic Medical Centers-
Harvard School of Public Health.
-Certificate of Completion, Penn State Leadership Academy

Clinical and Research Interests:
-Inflammatory Bowel Disease and Celiac Disease.
-Graduate Medical Education.

Katherine Falloon, MD, is a staff gastroenterologist at the Digestive Disease and Surgery Institute at the Cleveland Clinic and an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine. She is also the co-director of the intestinal ultrasound program at the Cleveland Clinic. Her clinical focus is in caring for patients in inflammatory bowel disease and her research interest is in extra-intestinal manifestations of inflammatory bowel disease. She is currently leading the Cohort for Healing Skin, Eye, and Extra-Intestinal Manifestations (CHASE-EIM), a multi-disciplinary research consortia related to extra-intestinal manifestations of inflammatory bowel disease. She has received funding from the Crohn's and Colitis Foundation, Pfizer, and the Digestive Disease and Surgery Institute's Chief Innovation and Research Award.

Jason Schairer is the Director of the Henry Ford IBD Center in Michigan. His interests include Interventional IBD with a focus on stricturotomy, addressing health care inequity, intimacy and sex in IBD, and improving medical education for providers of all levels. He received his medical degree from Wayne Statue University, and went on to complete a fellowship in gastroenterology at Providence Hospital in Michigan. He previously served as the Associate Program Director of the Henry Ford Gastroenterology and Hepatology fellowship, and continues to be involved in fellow education of IBD across the state of Michigan. He has been recognized for his teaching efforts, high quality care of IBD patients and contributions to patient education. He has presented at ESCCO, AIBD and DDW. He is Vice President of the Interventional IBD Special Interest Group of ASGE. He is President of the Oakland County Medical Society. He is also active on social media including Twitter and Youtube.

Gastroenterologist with an interest in inflammatory bowel diseases.

Paulo Gustavo Kotze is Adjunct Senior Professor of Surgery at the Catholic University in Curitiba, Paraná, Brazil. He rcompleted his General Surgery training at the Evangelical University Hospital in Curitiba (2000). He also completed his senior Fellowship in Colorectal Surgery at the Clinics Hospital from the Federal University of Parana (2002). Dr. Kotze achieved his Masters' Degree on Surgery at the Catholic University in 2008 and joined the faculty of medicine at the same university in 2011. He achieved his PhD degree studying the influence of biological therapy on surgical outcomes in Crohn´s disease, in the University of Campinas, in São Paulo, Brazil (UNICAMP) in 2015. Dr. Kotze was also an IBD advanced visiting fellow in the IBD unit at the University of Calgary (Cumming school of medicine), Canada, for the period of 2017-2018. Dr. Kotze is an experienced IBD surgeon and author of 3 books, 250+ pubmed peer-reviewed articles and multiple book chapters focused on Crohn´s disease and ulcerative colitis. He has special interest in the fields of biological therapy, epidemiology and surgery in IBD. Dr. Kotze was formely a committee member of S-ECCO (surgeons of ECCO) from 2015-2018 and a member of the ECCO EduCOM (educational committee), 2018-2021. He is an active member from the International Organization of Inflammatory Bowel Diseases (IOIBD). Currently, he is Professor of the Health Sciences Postgraduate Program at the Catholic University of Paraná, in Curitiba, Brazil. Dr Kotze is also a senior researcher for the National Brazilian Council of Research (CNPq).

Dr. Aline Charabaty is Professor of Medicine at the University of Maryland and the Director of the IBD Program at the University of Maryland Medical center. She is the Editor-in-Chief of the Crohn’s and Colitis 360 journal, and is past Vice-Chair of the AGA Research Foundation Executive Board, and past ACG Governor for Washington DC. Her work and advocacy were recognized by the Crohn’s and Colitis Foundation Excellence in Medicine Award in 2020 , the ACG Diversity Equity and Inclusion Award in 2025, and the AGA Beacon of Hope Award in 2026. Dr Charabaty uses social media to amplify medical education in IBD and is the founder of @MondayNightIBD a CME platform on twitter for which she received the Healio Disruptive Innovator Award in 2019. Dr Charabaty is a strong advocate for diversity and the professional advancement of women in GI. She is the Co-Founder of Scrubs & Heels, a foundation focused on empowering women in GI with the leadership skills, networking and mentorship to achieve professional goals and growth.

Katherine Falloon, MD, is a staff gastroenterologist at the Digestive Disease and Surgery Institute at the Cleveland Clinic and an assistant professor of medicine at the Cleveland Clinic Lerner College of Medicine. She is also the co-director of the intestinal ultrasound program at the Cleveland Clinic. Her clinical focus is in caring for patients in inflammatory bowel disease and her research interest is in extra-intestinal manifestations of inflammatory bowel disease. She is currently leading the Cohort for Healing Skin, Eye, and Extra-Intestinal Manifestations (CHASE-EIM), a multi-disciplinary research consortia related to extra-intestinal manifestations of inflammatory bowel disease. She has received funding from the Crohn's and Colitis Foundation, Pfizer, and the Digestive Disease and Surgery Institute's Chief Innovation and Research Award.

Phillip R. Fleshner, MD is the Director of Colorectal Surgery Research at Cedars-Sinai Medical Center. He holds the Shierley, Jesslyne, and Emmeline Widjaja Chair in Colorectal Surgery.

Dr. Fleshner's main clinical and research interests are directed towards optimizing outcomes and techniques in the surgical management of Crohn's disease and ulcerative colitis.

Dr. Fleshner has written numerous articles for peer-reviewed publications, including the Annals of Surgery, Journal of the American College of Surgeons, Diseases of the Colon and Rectum, Gut and the American Journal of Surgery.

Dr. Fleshner received his bachelor's degree from McGill University and his medical degree from the Albert Einstein College of Medicine. He completed his General Surgery Residency at the Mount Sinai Medical Center in New York and his Colorectal Surgery Fellowship at the Lahey Clinic in Boston.

He received the Sherman Prize in 2021.

Hans Herfarth is Director of the Multidisciplinary IBD Center at the University of North Carolina. His primary research interests focus on the development and evaluation of novel diagnostic and therapeutic approaches for patients with inflammatory bowel diseases (IBD). His work is particularly centered on the conceptualization and conduct of investigator-initiated clinical studies in IBD, supported by funding from the NIH, the Crohn’s & Colitis Foundation, and private and industry-associated foundations. Dr. Herfarth has authored more than 350 journal articles, book chapters, and review articles related to IBD.